US IVF Services Market by Cycle Type (Fresh IVF Cycle, Thawed IVF Cycle and Donor egg IVF cycle) and End-User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes)and Region – Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030
Product Overview
IVF requires sperm fertilization out of the body of a woman and implantation of the cell outside the womb. This is a form of treatment focused on assisted reproductive technology (ART) that helps with child reproduction and is used to treat fertility or genetic defects. It is the fertilizing process, involving the diffusion of eggs, sperm cell recovery and manual combination of egg and sperm in a laboratory environment to create an embryo. During further gestation, the embryo(s) are passed into the womb.
Market highlights
US IVF services, which is projected to hit USD 5,890 million by 2030 and experiences a CAGR of 8% in 2019 to 2030, was valued at USD 4020 million in 2018. The growth of the US IVF facilities market is driven by delayed female pregnancies, increased infertility levels, and increased gamete donations, higher discretionary income and rising IVF levels. Low understanding and complications associated with IVF therapy inhibit the development of the market. The development of fertility clinics, on the other hand, will generate new opportunities over the next few years. IVF is one of the most popular procedures that allow couples to cure infertility issues, single moms and the LGBT community can also help with these procedures. Processes of embryo banking cycles create major opportunities for the growth of the market in the forecast period.
US IVF Services Market Expected Market Growth
US IVF Services Market
Source: Fatpos Global
Request a FREE Sample Report: https://www.fatposglobal.com/sample-request-263
US IVF Services Market: Segments
Based on the end-users, the category of fertility clinics accounted for almost three-fifths of the total market share in 2019, and its advantageous position during the forecast period is projected. But from 2019 to 2028, the fastest CAGR of 14 percent is anticipated in the hospital group. The cycle-based group, which contributed almost two-thirds of the market share in 2018, held the greatest share of the fresh cycle (non-donor group) and is predicted to continue the largest share over the forecast period of 2019-2030. Additionally, the highest CAGR of 12.5 percent from 2019 to 2030 is expected in this section.
US IVF Services Market
US IVF Services Market: Market Dynamics
Drivers
Opportunities for the Players
Growing awareness of IVF therapy, the increasing prevalence of IVF in the United States, growing fertility rate and embryo banking activities, the technical development in IVF care, and postponed pregnancy patterns, the USA provides competitive prospects for players employed in the IVF services industry due to its high population base. The fertilization rate between the ages of 35 to 39 years via IVF procedures is substantially high, according to the Centers for Disease Control and Prevention (CDC). Eggs developed by the reproductive system for older women (more than 40 years of age) are not completely formed for fertilization. The threat of genetic diseases in the egg is therefore high. Thus, they turn towards In Vitro Process Fertilizations. The increased effect on the IVF services sector of same-sex marriages is modest. Owing to the vast rate of success, demand for IVF procedures is growing in homosexual couples. As a result, the demand for IVF services is expected to grow in same-sex marriages. The development of the IVF market is thus expected to raise the pattern of delayed pregnancy in women.
Increase in Urban Trends
The demand for services of Asia-Pacific IVF is marked by improved living conditions, a growing number of families delaying due to professional obligations, and financial stability patterns. Furthermore, massive growth in the services sector in these regions has resulted in stress and unhealthy lifestyles, the major source of infertility among men and women. The fast rise in nuclear families in advanced developing nations, such as India and China, has led to worry for the appropriate child-rearing among young couples which leads to parental delays.
Restraint
High Costs and Health Issues
IVF treatment issues such as multiple births and birth disorder weaknesses, three-parent IVF procedure limitations, sporadic compensation, and excessive IVF treatment costs hamper market development. Therefore, the FDA ordered to ensure health for embryos and mothers, the FDA has prohibited three-parent IVF procedures. This hinders In Vitro Fertilization market growth in the U.S. The cost and lower chances of success in services are the main restricting factors of this industry. During the first stage of embryo delivery, patients might not conceive. To facilitate pregnancy, patients must endure several processes and this raises the total costs. This operation costs about USD 3,000-USD 8,000 on average. This is a significant obstacle for people with low incomes when using the technique.
US IVF Services Market: Key Players
Boston IVF
Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
Fertility and Gynecology Center Monterey Bay IVF
Conceptions Reproductive Associates
Servy Massey Fertility Institute
Cardone Reproductive Medicine & Infertility
Fertility Center of San Antonio
Houston Fertility Center
New hope fertility center
Reproductive Medicine Associates of New Jersey.
Other Prominent Players
US IVF Services Market: Region
US & IVF Services Market is further segmented by region into:
US Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
COVID 19 Impact
As a result of this COVID-19 pandemic shutdown in the USA, some of the IVF subsectors have taken a major blow. The impact of COVID-19 on fertility treatment has been imprecisely explained, with information and advice from many relevant sources, including ASRM 2020 (American Reproductive Medicine Society). Some females delayed their IVF appointments, while others postponed their embryo transmission dates until the outbreak ends and life returns to normal.
US IVF Services Market report also contains analysis on:
US IVF Services Market Segments:
By Cycle Type
Fresh IVF Cycles (Non-Donor)
Thawed IVF Cycles (Non-Donor)
Donor Egg IVF Cycles
By End-User
Fertility Clinics
Hospitals
Surgical centers
Clinical research institutes
US IVF Services Market Dynamics
US IVF Services Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Related Report
IoT IAM Market
FinTech Blockchain Market
Digital Security Control Market
Biometric System Market
Authentication Services Market
User and Entity Behavior Analytics Market
Connected Worker Market
Track and Trace Solutions Market
Digital scent technology Market
Blockchain Technology in the Energy Industry Market
IVF requires sperm fertilization out of the body of a woman and implantation of the cell outside the womb. This is a form of treatment focused on assisted reproductive technology (ART) that helps with child reproduction and is used to treat fertility or genetic defects. It is the fertilizing process, involving the diffusion of eggs, sperm cell recovery and manual combination of egg and sperm in a laboratory environment to create an embryo. During further gestation, the embryo(s) are passed into the womb.
Market highlights
US IVF services, which is projected to hit USD 5,890 million by 2030 and experiences a CAGR of 8% in 2019 to 2030, was valued at USD 4020 million in 2018. The growth of the US IVF facilities market is driven by delayed female pregnancies, increased infertility levels, and increased gamete donations, higher discretionary income and rising IVF levels. Low understanding and complications associated with IVF therapy inhibit the development of the market. The development of fertility clinics, on the other hand, will generate new opportunities over the next few years. IVF is one of the most popular procedures that allow couples to cure infertility issues, single moms and the LGBT community can also help with these procedures. Processes of embryo banking cycles create major opportunities for the growth of the market in the forecast period.
US IVF Services Market Expected Market Growth
US IVF Services Market
Source: Fatpos Global
Request a FREE Sample Report: https://www.fatposglobal.com/sample-request-263
US IVF Services Market: Segments
Based on the end-users, the category of fertility clinics accounted for almost three-fifths of the total market share in 2019, and its advantageous position during the forecast period is projected. But from 2019 to 2028, the fastest CAGR of 14 percent is anticipated in the hospital group. The cycle-based group, which contributed almost two-thirds of the market share in 2018, held the greatest share of the fresh cycle (non-donor group) and is predicted to continue the largest share over the forecast period of 2019-2030. Additionally, the highest CAGR of 12.5 percent from 2019 to 2030 is expected in this section.
US IVF Services Market
US IVF Services Market: Market Dynamics
Drivers
Opportunities for the Players
Growing awareness of IVF therapy, the increasing prevalence of IVF in the United States, growing fertility rate and embryo banking activities, the technical development in IVF care, and postponed pregnancy patterns, the USA provides competitive prospects for players employed in the IVF services industry due to its high population base. The fertilization rate between the ages of 35 to 39 years via IVF procedures is substantially high, according to the Centers for Disease Control and Prevention (CDC). Eggs developed by the reproductive system for older women (more than 40 years of age) are not completely formed for fertilization. The threat of genetic diseases in the egg is therefore high. Thus, they turn towards In Vitro Process Fertilizations. The increased effect on the IVF services sector of same-sex marriages is modest. Owing to the vast rate of success, demand for IVF procedures is growing in homosexual couples. As a result, the demand for IVF services is expected to grow in same-sex marriages. The development of the IVF market is thus expected to raise the pattern of delayed pregnancy in women.
Increase in Urban Trends
The demand for services of Asia-Pacific IVF is marked by improved living conditions, a growing number of families delaying due to professional obligations, and financial stability patterns. Furthermore, massive growth in the services sector in these regions has resulted in stress and unhealthy lifestyles, the major source of infertility among men and women. The fast rise in nuclear families in advanced developing nations, such as India and China, has led to worry for the appropriate child-rearing among young couples which leads to parental delays.
Restraint
High Costs and Health Issues
IVF treatment issues such as multiple births and birth disorder weaknesses, three-parent IVF procedure limitations, sporadic compensation, and excessive IVF treatment costs hamper market development. Therefore, the FDA ordered to ensure health for embryos and mothers, the FDA has prohibited three-parent IVF procedures. This hinders In Vitro Fertilization market growth in the U.S. The cost and lower chances of success in services are the main restricting factors of this industry. During the first stage of embryo delivery, patients might not conceive. To facilitate pregnancy, patients must endure several processes and this raises the total costs. This operation costs about USD 3,000-USD 8,000 on average. This is a significant obstacle for people with low incomes when using the technique.
US IVF Services Market: Key Players
Boston IVF
Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
Fertility and Gynecology Center Monterey Bay IVF
Conceptions Reproductive Associates
Servy Massey Fertility Institute
Cardone Reproductive Medicine & Infertility
Fertility Center of San Antonio
Houston Fertility Center
New hope fertility center
Reproductive Medicine Associates of New Jersey.
Other Prominent Players
US IVF Services Market: Region
US & IVF Services Market is further segmented by region into:
US Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
COVID 19 Impact
As a result of this COVID-19 pandemic shutdown in the USA, some of the IVF subsectors have taken a major blow. The impact of COVID-19 on fertility treatment has been imprecisely explained, with information and advice from many relevant sources, including ASRM 2020 (American Reproductive Medicine Society). Some females delayed their IVF appointments, while others postponed their embryo transmission dates until the outbreak ends and life returns to normal.
US IVF Services Market report also contains analysis on:
US IVF Services Market Segments:
By Cycle Type
Fresh IVF Cycles (Non-Donor)
Thawed IVF Cycles (Non-Donor)
Donor Egg IVF Cycles
By End-User
Fertility Clinics
Hospitals
Surgical centers
Clinical research institutes
US IVF Services Market Dynamics
US IVF Services Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Related Report
IoT IAM Market
FinTech Blockchain Market
Digital Security Control Market
Biometric System Market
Authentication Services Market
User and Entity Behavior Analytics Market
Connected Worker Market
Track and Trace Solutions Market
Digital scent technology Market
Blockchain Technology in the Energy Industry Market
1. EXECUTIVE SUMMARY
2. USIVF
2.1. USIVFProduct Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MARKET DYNAMICS
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. RECENT DEVELOPMENT, POLICIES& REGULATORY LANDSCAPE
7. RISK ANALYSIS
7.1. Demand Risk Analysis
7.2. Supply Risk Analysis
8. USIVFINDUSTRY ANALYSIS
8.1. Porters Five Forces
8.1.1. Threat of New Entrants
8.1.2. Bargaining Power of Suppliers
8.1.3. Threat of Substitutes
8.1.4. Rivalry
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. USIVFMARKET
9.1. Market Size & forecast, 2019A-2030F
9.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
9.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10. USIVF: MARKET SEGMENTATION
10.1. By Regions
10.1.1. North America: (U.S. and Canada)
10.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
10.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
10.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.4. US: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
10.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
10.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2. By Cycle Type: Market Share (2020-2030F)
10.2.1. Fresh IVF, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.2. Thawed IVF, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.3. Donor Egg IVF, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3. By End User: Market Share (2020-2030F)
10.3.1. Fertility Clinics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.2. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.3. Surgical centres, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.4. Clinical Research Institutes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. COMPANY PROFILE
11.1. Boston IVF
11.1.1. Company Overview
11.1.2. Company Total Revenue (Financials)
11.1.3. Market Potential
11.1.4. Global Presence
11.1.5. Key Performance Indicators
11.1.6. SWOT Analysis
11.1.7. Product Launch
11.2. Fertility and Gynecology Center Monterey Bay IVF
11.3. Conceptions Reproductive Associates
11.4. Servy Massey Fertility Institute
11.5. Cardone Reproductive Medicine & Infertility
11.6. Fertility Center of San Antonio
11.7. Houston Fertility Center
11.8. New hope fertility center
11.9. Reproductive Medicine Associates of New Jersey
Consultant Recommendation
**The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. USIVF
2.1. USIVFProduct Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MARKET DYNAMICS
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. RECENT DEVELOPMENT, POLICIES& REGULATORY LANDSCAPE
7. RISK ANALYSIS
7.1. Demand Risk Analysis
7.2. Supply Risk Analysis
8. USIVFINDUSTRY ANALYSIS
8.1. Porters Five Forces
8.1.1. Threat of New Entrants
8.1.2. Bargaining Power of Suppliers
8.1.3. Threat of Substitutes
8.1.4. Rivalry
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. USIVFMARKET
9.1. Market Size & forecast, 2019A-2030F
9.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
9.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10. USIVF: MARKET SEGMENTATION
10.1. By Regions
10.1.1. North America: (U.S. and Canada)
10.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
10.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
10.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.4. US: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
10.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
10.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2. By Cycle Type: Market Share (2020-2030F)
10.2.1. Fresh IVF, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.2. Thawed IVF, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.3. Donor Egg IVF, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3. By End User: Market Share (2020-2030F)
10.3.1. Fertility Clinics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.2. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.3. Surgical centres, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.4. Clinical Research Institutes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. COMPANY PROFILE
11.1. Boston IVF
11.1.1. Company Overview
11.1.2. Company Total Revenue (Financials)
11.1.3. Market Potential
11.1.4. Global Presence
11.1.5. Key Performance Indicators
11.1.6. SWOT Analysis
11.1.7. Product Launch
11.2. Fertility and Gynecology Center Monterey Bay IVF
11.3. Conceptions Reproductive Associates
11.4. Servy Massey Fertility Institute
11.5. Cardone Reproductive Medicine & Infertility
11.6. Fertility Center of San Antonio
11.7. Houston Fertility Center
11.8. New hope fertility center
11.9. Reproductive Medicine Associates of New Jersey
Consultant Recommendation
**The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
